Literature DB >> 23910109

BRCA1 gene mutation in thymic malignant melanoma.

Eun Jue Yi1, Jong Ho Park, Hae Won Lee, Soo Youn Cho, Im Il Na, Moon Chul Kang.   

Abstract

We present a patient with triple primary malignancies: thyroid cancer, ovarian cancer, and thymic malignant melanoma. We suspected that gene mutations were involved in the occurrence of these multiple primary cancers, and blood analysis revealed the presence of BRCA1 gene mutations.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  13

Mesh:

Year:  2013        PMID: 23910109     DOI: 10.1016/j.athoracsur.2012.12.017

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

Review 1.  Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib.

Authors:  Daniel R Principe; Suneel D Kamath; Hidayatullah G Munshi; Nisha A Mohindra
Journal:  Oncologist       Date:  2019-11-01

Review 2.  Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib.

Authors:  Daniel R Principe; Suneel D Kamath; Hidayatullah G Munshi; Nisha A Mohindra
Journal:  Oncologist       Date:  2019-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.